Researchers at the University of Jyväskylä, in collaboration with the University of Turku's Institute of Biomedicine, ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

Paul Ehrlich performed pioneering research work in chemistry, medicine, physiology, histology, bacteriology, hematology and ...

A novel tool for rapidly identifying the genetic "fingerprints" of cancer cells may enable future surgeons to more accurately ...

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains bullish on Eupraxia ...

In a recent Zoom Interview with CBS Boston, The commissioner of Police, the Executive Director of the Belize National ...

A Tyneside biotech business is set to launch a recruitment drive after doubling the size of its Newcastle base.

A novel tool for rapidly identifying the genetic “fingerprints” of cancer cells may enable future surgeons to more accurately ...

(UroToday.com) The Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics 2025 held in Lugano, Switzerland was host to a session addressing the contemporary management of biochemically ...

A new AI-based tool for identifying colorectal cancer from tissue sample analysis has been developed at the . The new artificial neural network model has surpassed all its predecessors in ...